Covaset 200

Covaset 200 Softgel Capsule contains natural micronized progesterone, which is a key hormone for female reproductive health. This formulation of micronized progesterone is designed to be more readily absorbed by the body, ensuring effective hormone therapy for women with progesterone deficiency. Progesterone plays a critical role in regulating the menstrual cycle, supporting pregnancy, and maintaining the uterine lining for implantation after fertilization.

Covaset 200 is widely used in fertility treatments, particularly during assisted reproductive technologies (ART) such as in vitro fertilization (IVF). It is also prescribed for women experiencing progesterone deficiency, which can result in irregular cycles, pregnancy complications, or a higher risk of miscarriage. The micronized form of progesterone in Covaset 200 ensures better bioavailability, making it a preferred choice in hormone replacement therapy (HRT) for women undergoing fertility treatments or managing menopause-related hormonal imbalances.

Beyond fertility support, Covaset 200 is also recommended for women with hormonal imbalances due to conditions such as polycystic ovary syndrome (PCOS) or luteal phase defects. Its use in hormone replacement therapy (HRT) for menopausal women helps in balancing estrogen levels, reducing the risk of endometrial hyperplasia, and supporting overall well-being.

Common side effects include nausea, dizziness, headaches, mood changes, breast tenderness, and fatigue. Consult your healthcare provider if these side effects persist or worsen.

Covaset 200 is indicated for progesterone deficiency, fertility treatments, hormone replacement therapy (HRT), and maintenance of pregnancy.

Use under the supervision of a healthcare professional and follow the prescribed dosage strictly.

Store in a cool, dry place below 30°C, away from moisture and heat, and out of reach of children.